Extends the sale of the Alzheimer's semipostal stamp by the U.S. Postal Service for an additional six years.

The bill mandates the U.S. Postal Service to continue selling the Alzheimer's semipostal stamp for an additional six years. This stamp, which began sales on November 30, 2017, is intended to provide a convenient way for the public to contribute to Alzheimer's disease research. All proceeds from the stamp sales will be transferred to the National Institutes of Health for this purpose. The sale is governed by existing laws and regulations, with proceeds paid at least twice a year.

Extends the sale of the Alzheimer's semipostal stamp by the U.S. Postal Service for an additional six years.

The bill mandates the U.S. Postal Service to continue selling the Alzheimer's semipostal stamp for an additional six years. This stamp, which began sales on November 30, 2017, is intended to provide a convenient way for the public to contribute to Alzheimer's disease research. All proceeds from the stamp sales will be transferred to the National Institutes of Health for this purpose. The sale is governed by existing laws and regulations, with proceeds paid at least twice a year.